Analystreport

Leap Therapeutics Inc (NASDAQ: LPTX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com